Mannose-Magnetic Nanoparticle Production Service
Overview of Magnetic Glyconanoparticle
Comprised of metal elements, either in isolated or composite form, and their oxides, magnetic glyconanoparticles, particularly superparamagnetic magnetite, have emerged as a staple due to their superior biocompatibility and minimal toxicity. These iron oxide-based magnetic glyconanoparticles have increasingly captivated the scientific community, fostering advancements in understanding and application across various domains. Smaller-sized iron oxide magnetic glyconanoparticles are particularly favored in biological and biomedical applications. CD BioGlyco uses the advanced GlycoNano™ Platform, providing customized development and production of magnetic glyconanoparticles that integrate the controllable properties of magnetic materials with the biocompatibility and specificity of carbohydrate molecules. The surface chemistry of these magnetic glyconanoparticles is meticulously modulated to refine their physicochemical characteristics, enabling their deployment in diverse fields.
Empowering Precision Medicine with Mannose-Magnetic Nanotechnology
Among these, we perform a series of meticulously designed steps to create high-quality, mannose-coated maghemite nanoparticles.
Manufacture of Mannose-Magnetic Nanoparticle
- Synthesis of magnetic nanoparticles
We synthesize iron oxide nanoparticles by co-precipitating iron chloride precursors in deoxygenated water, followed by the addition of ammonium hydroxide. Wash the resulting black precipitate to adjust the pH to neutral.
- Sedimentation and acid treatment
Allow the solution to sediment under a magnetic field, discarding the supernatant. The black sediment is mixed with nitric acid and ferric nitrate, followed by dialysis against nitric acid.
- Coating with mannan
We mix the treated nanoparticles with mannan to coat the nanoparticles, adjusting the pH to neutral using ammonium hydroxide. This coating step is crucial for enhancing the nanoparticles' performance in various applications.
Characterization of Mannose-Magnetic Nanoparticle
After synthesis, characterization of the mannan-coated magnetic nanoparticle is conducted to determine key properties. We thoroughly assess the glyconanoparticles through two key components: the Glyconanoparticle Physicochemical Property Characterization Service, which evaluates the nanoparticles' size, charge, stability, and surface properties, and the Glyconanoparticle Molecule Interaction Analysis Service, which investigates the interactions between the glyconanoparticles and various biomolecules, ensuring optimal performance and compatibility in biomedical applications.
Workflow of Mannose-Magnetic Nanoparticle Manufacture

Publication
Technology: Fourier transform infrared spectroscopy (FTIR), Transmission electron microscopy (TEM)
Journal: 10.3390/catal9010007
IF: 10.6
Published: 2019
Results: In this study, the researchers optimized D-mannose-coated magnetic Fe3O4@OA@DP nanoparticles for immobilizing Escherichia coli cells that express recombinant glycerol dehydrogenase. TEM showed that the nanoparticles increased in size after mannose functionalization and effectively immobilized the E. coli cells. The optimal conditions for immobilization included a specific pH, cell concentration, and temperature, which maximized both yield and activity recovery. A certain buffer concentration was also found to be ideal for activity recovery. The immobilized cells performed better at higher pH and temperatures, retaining a high percentage of their initial enzyme activity after several hours of incubation, compared to a significant drop in free cells. Additionally, the immobilized cells maintained a substantial portion of their activity after multiple cycles, far outperforming free cells that retained only a minimal fraction of activity. The authors used the immobilized cells to convert glycerol to 1,3-dihydroxyacetone (DHA), achieving a significant improvement in production rate. This method eliminates the need for enzyme purification or expensive cofactors, reducing costs and making the immobilized cells highly promising for industrial applications, especially in DHA production.
Applications
- Mannose-magnetic nanoparticles act as macrophage-specific contrast agents for separating and identifying particular bacteria.
- The mannose-magnetic nanoparticle can be used for its ability to lower levels of IL-1β and TNF-α in the hippocampus to help manage inflammation.
- Mannose-magnetic nanoparticle plays a key role in blocking the surgery-upregulated HIF1-α/NF-κB pathway, essential for controlling inflammation and cellular stress.
Advantages
- Our synthesis process involves co-precipitation of iron chloride precursors in deoxygenated water and careful adjustment of pH, ensuring the production of high-quality iron oxide nanoparticles.
- We coat the nanoparticles with mannan, a process that enhances biocompatibility and specificity, making the nanoparticles particularly suitable for biological and biomedical applications.
- We provide customized development and production services, allowing clients to tailor the properties of the magnetic glyconanoparticles to specific needs and applications.
Frequently Asked Questions
- Why do we choose mannose for coupling with magnetic nanoparticles?
Mannose, a prevalent sugar found in numerous foods, plays a crucial role in the immune system as a component of the innate immune system's mannose-binding lectin (MBL). Its utility extends to serving as an economical backbone for synthesizing immunostimulatory and antitumor agents, enabling novel non-viral gene therapy approaches, and mediating natural killer cell function. - What technologies do we use for glyconanoparticle physicochemical property characterization service?
- Elemental Analyzer-based Glyconanoparticle Characterization Service
- HIC-based Glyconanoparticle Characterization Service
- XPS-based Glyconanoparticle Characterization Service
- FTIR-based Glyconanoparticle Characterization Service
- NMR-based Glyconanoparticle Characterization Service
- RS-based Glyconanoparticle Characterization Service
- SPR-based Glyconanoparticle Characterization Service
- TGA-based Glyconanoparticle Characterization Service
- Morphology-based Glyconanoparticle Characterization Service
- SANS-based Glyconanoparticle Characterization Service
CD BioGlyco offers high-quality and comprehensive Glyconanoparticle development Service via advanced techniques, ensuring superior biocompatibility and minimal toxicity. The modulated surface chemistry of our magnetic glyconanoparticles enables their deployment in a wide range of fields, from diagnostics research to targeted drug delivery research. If you want to obtain high-quality, mannose-coated magnetic nanoparticles, tailored to meet the specific needs of various scientific and industrial applications, contact us!
Reference
- Li, F.-L.; et al. Specific immobilization of Escherichia coli expressing recombinant glycerol dehydrogenase on mannose-functionalized magnetic nanoparticles. Catalysts. 2019, 9: 7.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




